XTX Topco’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,426
Closed -$8.67K 2331
2023
Q3
$8.67K Buy
+23,426
New +$13.4K ﹤0.01% 1428

XTX Topco's BXRX Position: Q4 2023 in Review

XTX Topco sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2023, closing a stake of 23,426 shares — an estimated $8.67K sold.

XTX Topco first reported a position in BXRX in Q3 2023 and held it in 1 quarter. The position peaked at $8.67K in Q3 2023. 2 funds tracked by Wall St. Rank hold BXRX as of Q4 2023.

  • XTX Topco reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • XTX Topco sold 23,426 Baudax Bio, Inc. Common Stock shares in Q4 2023, an estimated $8.67K.
  • XTX Topco first reported a position in Baudax Bio, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • XTX Topco's Baudax Bio, Inc. Common Stock position peaked at $8.67K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.